Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6392.5000 48.50 (0.76%)
NSE Jan 02, 2026 15:31 PM
Volume: 108.5K
 

6392.50
0.76%
ICICI Securities Limited
More than strong half-yearly performance (the management stresses that in a business like this can be lumpy) important narrative for Divi's is unprecedented capex to further augment capacities besides preparing for growing opportunities arising due to China plus one factor. It has earmarked an aggressive capex of ~| 3700 crore [| 1800 (existing plans) + | 400 (custom synthesis blocks) + | 1500 (greenfield Kakinada plant) crore], over and above ~| 2000 crore spent in last five years. Divi's remains a quintessential play on the Indian API/CRAMs segment with its product...
Divi's Laboratories .. has an average target of 6432.50 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended